CVE-2026-51871Devika v1.0 is vulnerable to Code Injection in the Runner.execute function in src/agents/runner/runner.py which allows an attacker to achieve arbitrary code execution by exploiting the direct executi…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
EPSS puts the chance of exploitation in the next 30 days at 0.40%, higher than 33% of scored CVEs.
Devika v1.0 is vulnerable to Code Injection in the Runner.execute function in src/agents/runner/runner.py which allows an attacker to achieve arbitrary code execution by exploiting the direct execution of LLM-generated content.
- CVSS
- 9.8 CRITICAL (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-94
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.40% (percentile 33)
- Assigned by
- mitre
- NVD analysis
- Deferred
- Record last updated
- Oct 1, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/stitionai/devika/issues/714
- https://gist.github.com/Ro1ME/3067a5bd69dcd35ffc98dc41ca611242
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.